VanEck Pharmaceutical ETF
PPH
PPH
49 hedge funds and large institutions have $131M invested in VanEck Pharmaceutical ETF in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-3
Holders Change %
-5.77%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
14
Reduced
11
Closed
7
Calls
–
Puts
$920K
Net Calls
-$920K
Net Calls Change
+$323K
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$9.34M |
| 2 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$8.93M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.77M |
| 4 |
VF
Virtu Financial
New York
|
+$1.45M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$523K |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$4.52M |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.45M |
| 3 |
Citigroup
New York
|
-$1.03M |
| 4 |
CCT
Country Club Trust
Kansas City,
Missouri
|
-$890K |
| 5 |
MA
Mutual Advisors
Omaha,
Nebraska
|
-$823K |
